Infection control supplies market seen reaching $61.44 billion by 2030

The infection control supplies market rose to $49.03 billion in 2026 and is projected to hit $61.44 billion by 2030, driven by higher healthcare spending, stricter prevention rules and broader use of protective products. North America held the largest share in 2025 as healthcare systems keep prioritizing hygiene and infection prevention.

Why it matters: - Infection control supplies are a core part of patient and staff safety in healthcare settings. - Rising demand for barriers, disinfectants and protective apparel signals continued spending on infection prevention as healthcare systems expand. - The market’s projected climb to $61.44 billion by 2030 points to sustained demand across hospitals, outpatient centers and diagnostic facilities.

What happened: - The infection control supplies market grew from $46.58 billion in 2025 to $49.03 billion in 2026. - The Business Research Company projects the market will reach $61.44 billion by 2030. - The report says the market has been supported by more hospital-acquired infections, more surgical procedures, wider healthcare infrastructure and higher PPE procurement. - North America held the largest market share in 2025. - The market coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report is available through a full market report. - A free sample of the market report is also available.

The details: - Infection control supplies include products that create protective barriers for the skin, nose and clothing against infectious pathogens. - These supplies are used mainly in healthcare settings to reduce the spread of infection between patients and healthcare professionals. - The 2026 report says the market’s growth is being supported by stronger preventive healthcare efforts, more spending on hospital safety protocols and stricter infection-prevention standards. - The report also highlights growing demand for environmentally friendly infection control products. - Market trends include more single-use protective supplies, wider use of high-efficiency disinfectants, more nitrile and non-latex gloves, growth in sustainable reusable protective apparel and tighter compliance with prevention guidelines. - The report notes that rising healthcare spending is a major driver of demand. - In June 2025, the Centers for Medicare & Medicaid Services projected U.S. national health expenditures would rise 8.2% in 2024, up from 7.5% in 2023.

Between the lines: - The forecast suggests infection control is shifting from a reactive purchase category to a standing budget priority. - The emphasis on sustainable and reusable products shows buyers are weighing environmental goals alongside safety requirements. - North America’s lead suggests mature healthcare systems are still generating the biggest demand, even as other regions remain important growth markets.

What's next: - The market is expected to continue a steady expansion through 2030. - Buyers are likely to keep favoring products that combine infection prevention, regulatory compliance and lower environmental impact. - Outpatient and diagnostic center growth should add another demand channel for suppliers. - The Business Research Company also said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, hotspot infographics, and updated graphics and tables.

The bottom line: - Infection control supplies are on track for steady growth as healthcare systems spend more on prevention, safety and compliance.